Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ERENUMAB
- Efficacy of Flunarizine Vs Amitriptyline in Prophylaxis of Migraine Prophylaxis
- Effect of Sildenafil in Individuals With Migraine Pretreated With Erenumab
- Effect of Levcromakalim in Individuals With Migraine Pretreated With Erenumab
- Screening Trial for Pain Relief in Schwannomatosis (STARFISH)
- Real World Effectiveness of Eptinezumab in Participants With Migraine
- Erenumab-aooe for Temporomandibular Disorders Management: TMD Cgrp Antibody RElief (TMD CARE)
- Erenumab-aooe for the Management of Trigeminal Neuropathic Pain.
- Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
- Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg vs Placebo as Adjuvant Treatment in Chronic Migraine -
- Efficacy of Erenumab in Chronic Cluster Headache
- Safety and Efficacy of Erenumab-aooe in Patients With Temporomandibular Disorder
- A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine
- Registry for Migraine - Structural and Functional MRI Before and After Erenumab Treatment
- Registry for Migraine - Clinical Core
- Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab
- Efficacy of Erenumab on Functional Impact of Migraine
- The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients
- Efficacy and Tolerability of Erenumab in the Management of Persistent Redness and Flushing in Rosacea
- Erenumab For Treatment of Hemicrania Continua
- A Study of Gastrointestinal Emptying Time in Adult Participants With Migraine Before and After Start of a mAb CGRP Antagonist
- Biomarker and Genetic Predictors of Erenumab Treatment Response
- Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine
- Erenumab for Idiosyncratic Facial Pain
- Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine
- Study of Quality of Life in Subjects With Chronic or High-frequency Episodic Migraine and Associated Comorbidities Treated With Erenumab
- Multidisciplinary Translational Approach to Investigate Mechanisms Predictors & Prevention of Persistent PTH
- Efficacy and Tolerability of Erenumab in Patients With Trigeminal Neuralgia
- A Functional MRI Study on Erenumab Treatment Effects in Episodic Migraine Patients
- Efficacy and Tolerability of Erenumab in the Prophylactic Treatment of Persistent Post-Traumatic Headache
- A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache
- Study of Sustained Benefit of Erenumab in Adult Episodic Migraine Patients
- Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine
- Efficacy and Safety of Erenumab in Pediatric Subjects With Episodic Migraine
- Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine
- Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine
- A Controlled Trial of Erenumab in Migraine Prevention
- Imaging the Migraine Brain Pre- and Post-Erenumab
- Erenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy Females
- Study to Evaluate the Effect of Erenumab on Blood Pressure When Given Concomitantly With Subcutaneous Sumatriptan
- A Safety and Efficacy Study to Evaluate AMG 334 in Migraine Prevention
- Treadmill Cardiovascular Safety Study of Erenumab (AMG 334)
- To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients
- Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine Prevention
- Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention
- A Study to Assess the Long-term Safety and Efficacy of Erenumab (AMG 334) in Chronic Migraine Prevention.
- A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention
- Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention
- Study of Erenumab (AMG 334) in Women With Hot Flashes
- Ascending Multiple-Doses of Erenumab (AMG 334) in Healthy Adults and in Migraine Patients
- Ascending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine Patients
Clinical trials list
click for details